
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Pediatric-Type Diffuse Low-Grade Gliomas: A Subgroup Defined by Peculiar Molecular Features and Distinct Prognostic Outcomes - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A2668AF1E83305A266005425BFD3.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cureus">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372413/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cureus">
<meta name="citation_title" content="Pediatric-Type Diffuse Low-Grade Gliomas: A Subgroup Defined by Peculiar Molecular Features and Distinct Prognostic Outcomes">
<meta name="citation_author" content="Abeer Javed">
<meta name="citation_author_institution" content="Pathology, Akhtar Saeed Medical &amp; Dental College, Rawalpindi, PAK">
<meta name="citation_publication_date" content="2025 Jul 23">
<meta name="citation_volume" content="17">
<meta name="citation_issue" content="7">
<meta name="citation_firstpage" content="e88575">
<meta name="citation_doi" content="10.7759/cureus.88575">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372413/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372413/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372413/pdf/cureus-0017-00000088575.pdf">
<meta name="description" content="Despite their biological and molecular heterogeneity, pediatric-type diffuse low-grade gliomas exhibit significantly different prognostic outcomes compared to their adult-type counterparts. Accurate diagnosis is essential to avoid aggressive ...">
<meta name="og:title" content="Pediatric-Type Diffuse Low-Grade Gliomas: A Subgroup Defined by Peculiar Molecular Features and Distinct Prognostic Outcomes">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Despite their biological and molecular heterogeneity, pediatric-type diffuse low-grade gliomas exhibit significantly different prognostic outcomes compared to their adult-type counterparts. Accurate diagnosis is essential to avoid aggressive ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372413/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372413">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.7759/cureus.88575"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/cureus-0017-00000088575.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372413%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372413/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372413/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372413/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cureus.png" alt="Cureus logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cureus" title="Link to Cureus" shape="default" href="http://www.cureus.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cureus</button></div>. 2025 Jul 23;17(7):e88575. doi: <a href="https://doi.org/10.7759/cureus.88575" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.7759/cureus.88575</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cureus%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cureus%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cureus%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cureus%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Pediatric-Type Diffuse Low-Grade Gliomas: A Subgroup Defined by Peculiar Molecular Features and Distinct Prognostic Outcomes</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Javed%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Abeer Javed</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Abeer Javed</span></h3>
<div class="p">
<sup>1</sup>
Pathology, Akhtar Saeed Medical &amp; Dental College, Rawalpindi, PAK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Javed%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Abeer Javed</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<div class="cg p">Editors: <span class="name western">Alexander Muacevic</span>, <span class="name western">John R Adler</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff-1">
<sup>1</sup>
Pathology, Akhtar Saeed Medical &amp; Dental College, Rawalpindi, PAK </div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">
Abeer Javed <span>abeerjaved19@gmail.com</span>
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Accepted 2025 Jul 23; Collection date 2025 Jul.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025, Javed et al.</div>
<p>This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372413</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Despite their biological and molecular heterogeneity, pediatric-type diffuse low-grade gliomas exhibit significantly different prognostic outcomes compared to their adult-type counterparts. Accurate diagnosis is essential to avoid aggressive overtreatment and to enable exploration of relevant molecular targets for personalized therapy. This review provides a comprehensive overview of the epidemiology, clinical presentation, radiologic findings, histopathologic features, and key molecular events characterizing the newly defined WHO subgroup "pediatric-type diffuse low-grade gliomas." The review also outlines the conventional treatment modalities, including surgery, chemotherapy, and radiotherapy, while discussing their limitations and adverse effects. In addition, emerging therapeutic strategies based on molecular targets are briefly highlighted, offering a glimpse into current clinical trials and FDA-approved targeted therapies. Data were retrieved from credible scientific sources including PubMed, Google Scholar, and the 2021 WHO Classification of Central Nervous System Tumors. The newly established molecular subgroup comprises four distinct entities: 1) Diffuse astrocytoma, MYB or MYBL1-altered; 2) Angiocentric glioma; 3) Polymorphous low-grade neuroepithelial tumor of the young; and 4) Diffuse low-grade glioma, MAPK pathway-altered. Unlike circumscribed astrocytic gliomas, these tumors exhibit partial infiltrative behavior. However, they tend to have a more favorable prognosis than adult-type diffuse gliomas, IDH-mutant. Circumscribed gliomas are typically managed with gross total resection and show a lower recurrence rate in comparison to this newly recognized subgroup. While surgical resection remains curative for small, superficial tumors, deeper or more infiltrative variants may recur following subtotal resection. A thorough understanding of the clinicopathological and molecular features of these gliomas is imperative for accurate classification and appropriate therapeutic intervention.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> brain neoplasms, classification, clinical trial, molecular diagnostics, molecular targeted therapy</p></section></section><section id="sec1"><h2 class="pmc_sec_title">Introduction and background</h2>
<p>Central nervous system (CNS) tumors, including brain tumors, are the most common type of solid tumor and the leading cause of cancer-related deaths among individuals aged 0-19 years [<a href="#REF1" class="usa-link" aria-describedby="REF1">1</a>]. CNS tumors result in 0.7 deaths per 100,000 children diagnosed, establishing them as the leading cause of cancer-related mortality in the pediatric population [<a href="#REF2" class="usa-link" aria-describedby="REF2">2</a>,<a href="#REF3" class="usa-link" aria-describedby="REF3">3</a>]. Within this category of central nervous system tumors, gliomas alone account for 50% of the cases [<a href="#REF4" class="usa-link" aria-describedby="REF4">4</a>,<a href="#REF5" class="usa-link" aria-describedby="REF5">5</a>]. In adults, high-grade gliomas are more prevalent; however, low-grade gliomas predominate in the pediatric age group [<a href="#REF4" class="usa-link" aria-describedby="REF4">4</a>,<a href="#REF5" class="usa-link" aria-describedby="REF5">5</a>].</p>
<p>Pediatric low-grade gliomas account for approximately 30% of childhood CNS tumors. These are classified as World Health Organization (WHO) grade I or II tumors and encompass a diverse range of histological subtypes that can arise throughout the neuroaxis [<a href="#REF6" class="usa-link" aria-describedby="REF6">6</a>,<a href="#REF7" class="usa-link" aria-describedby="REF7">7</a>]. Pediatric low-grade gliomas are classified into three distinct subgroups: circumscribed astrocytic gliomas, glioneuronal and neuronal tumors, and the recently defined pediatric-type diffuse low-grade gliomas [<a href="#REF4" class="usa-link" aria-describedby="REF4">4</a>].</p>
<p>Pediatric-type diffuse low-grade gliomas, like their adult counterparts, have an infiltrative border. The formation of secondary structures of Scherer is a consistent feature that renders the acquisition of clear surgical margins difficult, if not impossible, in certain deep-seated tumors [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>]. A unique subset of pediatric diffuse gliomas carrying the IDH gene mutation was highlighted by Ferris et al. In their study, whole-exome sequencing identified three cases of IDH-mutant diffuse gliomas in pediatric patients. However, these were thought to be genetically unique from adult-type tumors, since they were ATRX non-mutated and lacked TERT promoter mutations [<a href="#REF9" class="usa-link" aria-describedby="REF9">9</a>]. This review discusses the clinicopathologic and molecular features of pediatric-type diffuse low-grade gliomas, current treatment limitations, and emerging therapies to enhance understanding, support accurate diagnosis, and guide precise management.</p></section><section id="sec2"><h2 class="pmc_sec_title">Review</h2>
<p>Pediatric-type diffuse low-grade gliomas</p>
<p>Diffuse astrocytoma, MYB- or MYBL1-altered, CNS WHO grade 1, is a newly recognized tumor entity in the 2021 World Health Organization classification of central nervous system tumors. Diagnosis requires an integrated approach, considering both histologic and molecular features, in keeping with the 2014 ISN-Haarlem guidelines and C-IMPACT-NOW updates [<a href="#REF10" class="usa-link" aria-describedby="REF10">10</a>,<a href="#REF11" class="usa-link" aria-describedby="REF11">11</a>].</p>
<p>Diagnostic Criteria</p>
<p>Diffuse astrocytoma, MYB- or MYBL1-altered, is a diffusely infiltrative astrocytic neoplasm that lacks histomorphological features indicative of an anaplastic nature [<a href="#REF7" class="usa-link" aria-describedby="REF7">7</a>]. For a definitive diagnosis, the tumor must be IDH-wild type and H3-wild type, and should exhibit a structural variant involving either the MYB or MYBL1 gene. In cases where such genetic alterations are not detectable, a distinct DNA methylation profile characteristic of diffuse astrocytoma, MYB- or MYBL1-altered, may be sufficient to establish the diagnosis. This rare tumor entity represents approximately 2% of the pediatric low-grade glioma spectrum, and accounts for only 0.3% of all tumors surgically removed in the context of epilepsy management [<a href="#REF12" class="usa-link" aria-describedby="REF12">12</a>-<a href="#REF14" class="usa-link" aria-describedby="REF14">14</a>].</p>
<p>These histologically indolent-appearing tumors often present in pediatric patients with persistent, treatment-resistant epileptic seizures. As a result, along with glioneuronal tumors, they are classified within the broader clinical category of long-term epilepsy-associated tumors (LEATs). In the largest case series published by Chiang et al. comprising 46 gliomas from St. Jude’s Hospital, the median age of presentation was 5 years, and no gender predilection was observed. The majority of the tumors were localized in the cerebral cortex, followed by the cerebral white matter/deep gray nuclei or brainstem. Epilepsy was the most frequent presentation of tumors located in cortical lobes; raised intracranial pressure in neoplasms involving the white matter/deep gray nuclei, whereas multiple cranial nerve deficits were observed in brainstem tumors [<a href="#REF14" class="usa-link" aria-describedby="REF14">14</a>].</p>
<p>Given the tumor’s low-grade, infiltrative histologic features, the radiologic findings are consistent with those of an indolent glioma. Preoperative magnetic resonance (MR) images reveal a T1 iso-intense to hypo-intense tumor with a mixed signal or hyperintensity on T2-FLAIR. These tumors are mostly well-delineated, although some may exhibit a diffuse growth pattern. In rare cases, large cysts may also be present [<a href="#REF15" class="usa-link" aria-describedby="REF15">15</a>,<a href="#REF16" class="usa-link" aria-describedby="REF16">16</a>].</p>
<p>The tumor exhibits characteristic histology of a low-grade astroglial neoplasm with a diffusely infiltrative border. Aggressive histologic features such as overt nuclear pleomorphism, brisk mitotic activity, microvascular proliferation, and necrosis are sometimes typically absent. Both subpial condensation and a diffusely infiltrative growth pattern were consistently observed histologic features of the neoplasm. Occasionally, tumor cells exhibited a subtle angiocentric pattern of growth. The characteristic molecular profile can be investigated using multiple ancillary studies, including immunohistochemistry, RNA sequencing, interphase FISH, and qualitative PCR-based sequencing [<a href="#REF12" class="usa-link" aria-describedby="REF12">12</a>]. These tumors are specifically characterized by MYB or MYBL1 alterations and a lack of mutations in IDH1, IDH2, TP53, ATRX, and H3 genes. Methylation studies using t-distributed stochastic neighbor embedding (t-SNE) analysis identified a single cluster, regardless of tumor site, neuroradiologic findings, or histopathologic features, indicating that this neoplasm is molecularly distinct despite overlapping clinicopathologic characteristics (Figure <a href="#FIG1" class="usa-link">1</a>) [<a href="#REF14" class="usa-link" aria-describedby="REF14">14</a>].</p>
<figure class="fig xbox font-sm" id="FIG1"><h3 class="obj_head">Figure 1. Histopathology of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372413_cureus-0017-00000088575-i01.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f37/12372413/78f7186fe5b4/cureus-0017-00000088575-i01.jpg" loading="lazy" height="564" width="750" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/FIG1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Tumors with an angiocentric glioma pattern exhibit prominent angiocentric growth and areas resembling diffuse astrocytoma. Entrapped neurons are visible. (B) Tumors with a diffuse astrocytoma pattern often display varying degrees of angiocentric growth around small blood vessels. (C) Isomorphic diffuse glioma reveals subtle increases in cellularity. (D) The tumor shows widespread infiltration of CNS parenchyma, with numerous entrapped neurofilament-positive axons. (E) Tumor cells demonstrate GFAP positivity. (F,G) Tumor cells with angiocentric growth are negative for Olig2 and Sox10. (H) Angiocentric tumor cells show MAP2 immunoreactivity. (I) A characteristic finding is the perinuclear dot-like EMA immunoreactivity. Scale bar: 100 μm.</p>
<p>Image Source: Moreira et al. [<a href="#REF17" class="usa-link" aria-describedby="REF17">17</a>], shared under the Creative Commons CC-BY-NC license.</p>
<p>CNS: central nervous system; GFAP: Glial fibrillary acidic protein; EMA: Epithelial membrane antigen; MAP2: Microtubule-associated protein 2; Olig2: Oligodendrocyte transcription factor 2</p></figcaption></figure><p>Angiocentric glioma, CNS WHO grade 1</p>
<p>Angiocentric glioma is a relatively rare, indolent astrocytic tumor first described in 2005 in two different studies by Wang et al. and Lellouch-Tubiana [<a href="#REF18" class="usa-link" aria-describedby="REF18">18</a>,<a href="#REF19" class="usa-link" aria-describedby="REF19">19</a>]. It was then formally incorporated as a distinct tumor entity in the WHO classification of tumors of the central nervous system in 2007 [<a href="#REF16" class="usa-link" aria-describedby="REF16">16</a>].</p>
<p>WHO Diagnostic Criteria</p>
<p>Essential Features: Angiocentric glioma is a low-grade glial neoplasm with a focal angiocentric pattern of growth and a predominant solid or diffuse architecture. These tumors comprising monotonous spindle cells exhibiting immunohistochemical and ultrastructural features consistent with an astrocytoma or ependymoma.</p>
<p>Desirable Features: Angiocentric glioma is a diffusely infiltrative, low-grade glioma characterized by several desirable histological and molecular features. Notably, it shows no evidence of anaplasia and often harbors MYB alterations, with a DNA methylation profile closely resembling that of diffuse glioma, MYB- or MYBL1-altered. This tumor affects individuals across a wide age range, from infancy to over 80 years, with a median age of 15 years and a slight male predominance [<a href="#REF20" class="usa-link" aria-describedby="REF20">20</a>]. Childhood-onset, drug-refractory seizures are the most common presenting feature; however, patients may exhibit a wide array of symptoms including headaches, cranial nerve deficits, generalized weakness, nausea, vomiting, gait disturbances, nystagmus, and spinal impairment [<a href="#REF21" class="usa-link" aria-describedby="REF21">21</a>].</p>
<p>On MRI, angiocentric gliomas typically appear as unifocal, well-delineated, superficial supratentorial cortical tumors that are T1 hypointense and T2-FLAIR hyperintense. Most tumors are non-enhancing and display a characteristic “stalk sign”-a stalk-like extension into the lateral ventricles. Although uncommon, brainstem and thalamic involvement has been documented, often associated with a distinct molecular profile. Other radiologic findings may include restricted brain atrophy, calcification, prominent cystoid changes, and a rich vascular supply [<a href="#REF22" class="usa-link" aria-describedby="REF22">22</a>].</p>
<p>Histologically, these tumors demonstrate a unique angiocentric growth pattern with bland, uniform bipolar spindle cells arranged concentrically around blood vessels. Cellular pleomorphism, anisonucleosis, microvascular proliferation, necrosis, and mitotic activity are generally absent. Some cases may exhibit nuclear palisading, myxoid changes, or calcifications. The tumor typically shows subpial condensation, with nuclei aligned almost perpendicularly to the pia mater. Interspersed neurons are consistently observed; whether they are neoplastic or represent entrapped cortical neurons remains unclear [<a href="#REF18" class="usa-link" aria-describedby="REF18">18</a>, <a href="#REF23" class="usa-link" aria-describedby="REF23">23</a>]. Focal cortical dysplasia has been noted in the adjacent cortex in several cases [<a href="#REF20" class="usa-link" aria-describedby="REF20">20</a>].</p>
<p>Immunohistochemically, tumor cells consistently express GFAP, S100, and vimentin, with a distinctive perinuclear dot-like EMA positivity. They are negative for IDH1, IDH2, p53, Olig2, and NeuN, and the Ki-67 proliferation index remains low, typically under 5%, consistent with WHO Grade I status [<a href="#REF19" class="usa-link" aria-describedby="REF19">19</a>].</p>
<p>Molecularly, nearly all tumors exhibit gene rearrangements or copy number alterations involving the MYB locus on chromosome 6q23 [<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>]. 3. The most consistent genetic alteration is the MYB: QKI fusion, involving the proto-oncogene MYB and QKI, a gene encoding an RNA-binding protein crucial for oligodendrocyte and Schwann cell development. Although rare, fusion partners other than QKI have also been identified [<a href="#REF25" class="usa-link" aria-describedby="REF25">25</a>]. Importantly, mutations commonly seen in higher-grade gliomas, such as IDH1, IDH2, ATRX, TP53, and H3, are absent in angiocentric gliomas. The DNA methylation profile of this tumor closely aligns with that of diffuse astrocytoma, MYB- or MYBL1-altered [<a href="#REF26" class="usa-link" aria-describedby="REF26">26</a>].</p>
<figure class="fig xbox font-sm" id="FIG2"><h3 class="obj_head">Figure 2. Angiocentric glioma, CNS WHO Grade 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372413_cureus-0017-00000088575-i02.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f37/12372413/52f682844e75/cureus-0017-00000088575-i02.jpg" loading="lazy" height="851" width="750" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/FIG2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Smear preparation reveals bipolar cells (arrows) with long processes, resembling pilocytic astrocytoma (Hematoxylin and Eosin, 200x). (B) At low magnification, the tumor shows mostly parallel neoplastic bipolar cells arranged in a distinctive angiocentric pattern, (arrows) (H&amp;E, 100x). (C) The myxoid component is markedly hypocellular but retains the angiocentric configuration (arrows) (H&amp;E, 100x). (D) Tumor cells show diffuse GFAP expression, particularly highlighting the angiocentric pattern (GFAP, polyclonal, Ventana, 200x). (E) Strong D2-40 expression is seen in tumor cells (arrows) (clone D2-4, DakoCytomation, 400x). (F) EMA shows moderate cytoplasmic staining, with perinuclear accentuation noted in some cells (arrows) (EMA, clone E29, Dako, 400x).</p>
<p>Image Source: Almubarak et al. [<a href="#REF27" class="usa-link" aria-describedby="REF27">27</a>] shared under the Creative Commons CC BY-NC license</p>
<p>GFAP: Glial fibrillary acidic protein; EMA: Epithelial membrane antigen</p></figcaption></figure><p>Polymorphous low-grade neuroepithelial tumor of the young (PLNTY)</p>
<p>Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) occurs predominantly in the pediatric age group as initially described in the pilot case series. However, with subsequent new case reports, tumors in the adult population also became evident [<a href="#REF21" class="usa-link" aria-describedby="REF21">21</a>].</p>
<p> WHO Diagnostic Criteria</p>
<p>The WHO diagnostic criteria for diffuse glioma, MAPK-pathway altered, include several distinct features: 1) the tumor must be a low-grade glial neoplasm exhibiting at least focal infiltrative morphology; 2) there should be oligodendroglioma-like histomorphological features present in at least part of the tumor; 3) the tumor must demonstrate low mitotic activity, consistent with its low-grade nature [<a href="#REF28" class="usa-link" aria-describedby="REF28">28</a>]. Another essential criterion is the diffuse aberrant expression of CD34 throughout the tumor. Additionally, the tumor must be IDH-wild type, indicating the absence of IDH mutations [<a href="#REF29" class="usa-link" aria-describedby="REF29">29</a>]. Finally, there must be unequivocal evidence of a mutation in BRAF or FGFR2 or FGFR3, or in any of the other genes involved in the MAPK signaling pathway. The majority of tumors exhibit a variable degrees of calcification ranging from small calcospherules to large confluent calcifications, which, in addition to 1p/19q wild-type status, are a desirable diagnostic criterion for this entity [<a href="#REF30" class="usa-link" aria-describedby="REF30">30</a>].</p>
<p>PLNTY occurs predominantly in the pediatric age group as initially described in the pilot case series; however, with subsequent new case reports, tumors in the adult population also became evident [<a href="#REF31" class="usa-link" aria-describedby="REF31">31</a>]. Tumors tend to occur over a wide age range (4-57 years) without any gender predilection. As with other low-grade glioneuronal and glial neoplasms occurring in the temporal lobe, epilepsy is the most common presenting feature, followed by headache and visual disturbances. The temporal lobe is the most common location, followed by the occipital and frontal lobes [<a href="#REF32" class="usa-link" aria-describedby="REF32">32</a>].</p>
<p>Typical radiologic features include a temporal lobe cortical or subcortical mass lesion with well-delineated borders (on T1- and T2-weighted MR images), confluent calcifications (occasionally prominent central calcification with small peripheral scattered calcifications), and a mixed solid-cystic appearance. Calcifications are most evident on a computed tomography (CT) scan. The heterogeneous signal intensity on T1- and T2-weighted MR images is due to hypointensity in the region of confluent calcifications and hyperintensity in the peripheral regions. Occasionally, the tumor presents with edema or mass effect [<a href="#REF33" class="usa-link" aria-describedby="REF33">33</a>,<a href="#REF34" class="usa-link" aria-describedby="REF34">34</a>].</p>
<p>As the name suggests, these tumors exhibit polymorphous morphology, with both astroglial and oligodendroglioma-like features, the latter being more commonly observed in most cases. Tumors with spindle cells, pleomorphic cells, and ependymoma-type rosettes have also been reported. However, aggressive histomorphologic features such as markedly increased cellularity, microvascular proliferation, brisk mitotic activity, atypical mitotic figures, or areas of geographic tumor necrosis are, by definition, absent [<a href="#REF35" class="usa-link" aria-describedby="REF35">35</a>]. A hallmark of these tumors is calcification, ranging from tiny calcospherules to chunky, confluent, radiologically and histologically prominent calcifications. Characteristic features of low-grade circumscribed astrocytic neoplasms, such as Rosenthal fibers, myxoid microcysts, and eosinophilic granular bodies, are typically absent, as is the presence of dysmorphic neurons and ependymal rosettes, which are seen in glioneuronal tumors and ependymomas, respectively [<a href="#REF36" class="usa-link" aria-describedby="REF36">36</a>].</p>
<p>PLNTYs are negative for IDH1 and IDH2 immunomarkers. Diffuse immunoreactivity for Olig2 and GFAP, along with retained ATRX, as well as strong expression of CD34, is a characteristic finding. CD34 is also positive in several other low-grade epilepsy-associated neuroepithelial tumors (LEATs) such as gangliogliomas, DNETs, pleomorphic xanthoastrocytomas, and areas of focal cortical dysplasia. However, CD34 is particularly useful in differentiating PLNTY from oligodendrogliomas, which are CD34-negative [<a href="#REF37" class="usa-link" aria-describedby="REF37">37</a>].</p>
<p>MAPK-pathway alterations are a consistent feature of polymorphous low-grade neuroepithelial tumor of the young. IDH1 and IDH2 mutations, as well as 1p/19q co-deletions, are absent in these tumors [<a href="#REF38" class="usa-link" aria-describedby="REF38">38</a>]. Mutations involving BRAF p.V600E are the most common, followed by alterations in FGFR2 or FGFR3 (both being mutually exclusive). FGFR2:SHTN1, FGFR2:INA, and FGFR3:TACC3 fusions have been identified using RNA sequencing. FGFR:CTNNA3 gene fusion, which is exclusive to this tumor, has also been recently reported, as has partial duplication of NTRK2 in a single case. PLNTYs display a DNA methylation profile clustering close to gangliogliomas [<a href="#REF39" class="usa-link" aria-describedby="REF39">39</a>] (Figure <a href="#FIG3" class="usa-link">3</a>).</p>
<figure class="fig xbox font-sm" id="FIG3"><h3 class="obj_head">Figure 3. Polymorphous low-grade neuroepithelial tumor of the young, CNS WHO Grade 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372413_cureus-0017-00000088575-i03.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f37/12372413/dde18e013bef/cureus-0017-00000088575-i03.jpg" loading="lazy" height="825" width="750" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/FIG3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) T1-weighted imaging (T1WI) shows hypointensity. (B) T2-weighted imaging (T2WI) demonstrates hyperintensity with a “salt and pepper” appearance. (C) Histologically, the tumor consists of oligodendroglioma-like cells with interspersed thin-walled capillary channels (H&amp;E, 20x). (D) Abundant microcalcifications are present within the lesion (H&amp;E, 10x). (E) Tumor cells show intense and widespread CD34 immunopositivity (CD34, 4x). (F) BRAF V600E mutation is expressed in neoplastic cells (BRAF V600E, 40x).</p>
<p>Image Source: Fabbri et al. [<a href="#REF40" class="usa-link" aria-describedby="REF40">40</a>] shared under the under a CC-BY-NC-ND 4.0 International License.</p></figcaption></figure><p>Diffuse glioma, MAPK-pathway altered</p>
<p>Diffuse glioma, MAPK-pathway altered, is a newly recognized tumor entity included in the WHO 2021 classification and defined by strict diagnostic criteria [<a href="#REF1" class="usa-link" aria-describedby="REF1">1</a>].</p>
<p>WHO diagnostic criteria</p>
<p>This entity refers to an infiltrative low-grade glial neoplasm exhibiting morphologic features of oligodendroglioma, astrocytoma, or mixed histology. It must exhibit either a fibroblast growth factor receptor 1 tyrosine kinase domain internal tandem duplication, a fibroblast growth factor receptor 1 mutation, or a mutation in BRAF p.V600E. In contrast, IDH and histone gene mutations, as well as CDKN2A deletions, must be absent. The majority of these tumors occur in the pediatric population, with no definite gender predilection. Although they can arise throughout the craniospinal neuroaxis, the cerebral hemispheres are the typical site, particularly the temporal lobe, similar to other low-grade epileptogenic neoplasms [<a href="#REF38" class="usa-link" aria-describedby="REF38">38</a>]. Radiologically, the tumor appears as a T2-FLAIR and T2 hyperintense, non-enhancing mass within the cerebral cortex, most frequently in the temporal lobe [<a href="#REF41" class="usa-link" aria-describedby="REF41">41</a>].</p>
<p>Histopathologic examination of these tumors reveals features characteristic of a low-grade infiltrative glial neoplasm. Tumors may exhibit morphology resembling pure oligodendroglioma or pure astrocytoma, while some show mixed histologic patterns. IDH-mutant diffuse gliomas in adults exhibit widely infiltrative tumor margins, which render the achievement of clear surgical margins cumbersome if not impossible. In contrast, diffuse low-grade glioma (MAPK pathway altered) shares morphologic features with other pediatric diffuse (non-IDH-mutant) low-grade gliomas and, therefore, displays minimal infiltration of the surrounding cortex, much less than adult-type IDH-mutated gliomas but more than pediatric circumscribed gliomas (such as pilocytic astrocytoma and pleomorphic xanthoastrocytoma) [<a href="#REF42" class="usa-link" aria-describedby="REF42">42</a>]. Features suggestive of aggressive biologic behavior, such as increased tumor cellularity, cellular pleomorphism, microvascular proliferation, and coagulative tumor cell necrosis, are not features of this tumor. Subpial condensation has been reported in certain cases. Interestingly, tumors characterized by FGFR1 alteration exhibit oligodendroglioma-like morphology and overlapping features with dysembryoplastic neuroepithelial tumors. These are frequently multinodular and exhibit clear cells with rounded nuclei and inconspicuous nucleoli. Relevant differential diagnostic considerations for this histologic appearance and molecular subtype include polymorphous low-grade neuroepithelial tumor of the young, which consistently shows diffuse non-vascular expression of CD34; adult-type diffuse astrocytoma and oligodendroglioma, which harbor characteristic 1p/19q co-deletion [<a href="#REF28" class="usa-link" aria-describedby="REF28">28</a>]. Conversely, BRAF p.V600E-mutated tumors reveal a fibrillary background with elongated to spindled cells showing mild to moderate cytologic atypia. Subpial condensation of the tumor cells may be seen. Pilocytic astrocytoma, pleomorphic xanthoastrocytoma, ganglioglioma, IDH-mutant gliomas, and diffuse midline glioma H3K27M-altered are included in the differential diagnoses. Low-grade circumscribed gliomas are easily distinguished based on the presence of Rosenthal fibers and eosinophilic granular bodies [<a href="#REF43" class="usa-link" aria-describedby="REF43">43</a>]. Gangliogliomas harbor dysplastic neuronal elements, separating them into a distinct category of their own. Immunohistochemistry and/or molecular testing conclusively excludes the presence of IDH and histone gene mutations, ruling out the last two differential diagnoses [<a href="#REF1" class="usa-link" aria-describedby="REF1">1</a>,<a href="#REF44" class="usa-link" aria-describedby="REF44">44</a>] (Table <a href="#TAB1" class="usa-link">1</a> and Figure <a href="#FIG4" class="usa-link">4</a>).</p>
<section class="tw xbox font-sm" id="TAB1"><h3 class="obj_head">Table 1. Immunophenotypic features and differential diagnoses of pediatric-type diffuse low-grade gliomas.</h3>
<div class="caption p"><p>MYB: V-myb avian myeloblastosis viral oncogene homolog; MYBL1: V-myb avian myeloblastosis viral oncogene homolog-like 1; IDH1: Isocitrate dehydrogenase 1; GFAP: Glial fibrillary acidic protein; ATRX: Alpha-Thalassemia mental retardation syndrome X-linked; BRAF: B-Raf proto-oncogene, serine/threonine kinase; Olig-2: Oligodendrocyte lineage transcription factor 2; EMA: Epithelial membrane antigen; CD34: Cluster of Differentiation 34, MN-1: Meningioma 1 proto-oncogene; H3F3A G34R/V: H3.3 histone A, mutation where glycine at position 34 is replaced by arginine [R] or valine [V]; H3K27M: surrogate immunomarker for mutation in H3F3A or HIST1H3B/C gene where lysine 27 is replaced by methionine; DNET: Dysembryoplastic neuroepithelial tumor</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Tumor Type</td>
<td rowspan="1" colspan="1">Marker</td>
<td rowspan="1" colspan="1">Result/Status</td>
<td rowspan="1" colspan="1">Differentials</td>
</tr>
<tr>
<td rowspan="6" colspan="1">Diffuse Astrocytoma, MYB/MYBL1-Altered</td>
<td rowspan="1" colspan="1">IDH1 p.R132H</td>
<td rowspan="1" colspan="1">Negative</td>
<td rowspan="1" colspan="1">Astrocytoma, IDH-mutant</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">GFAP</td>
<td rowspan="1" colspan="1">Positive</td>
<td rowspan="1" colspan="1">Astrocytoma, IDH-wild type</td>
</tr>
<tr>
<td rowspan="1" colspan="1">ATRX</td>
<td rowspan="1" colspan="1">Retained expression</td>
<td rowspan="1" colspan="1">Angiocentric glioma</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">EMA</td>
<td rowspan="1" colspan="1">Dot-like intracytoplasmic [<a href="#REF14" class="usa-link" aria-describedby="REF14">14</a>]</td>
<td rowspan="1" colspan="1">Ganglioglioma</td>
</tr>
<tr>
<td rowspan="1" colspan="1">CD34</td>
<td rowspan="1" colspan="1">Negative</td>
<td rowspan="1" colspan="1">CD34-negative gliomas</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Ki-67 Proliferation Index</td>
<td rowspan="1" colspan="1">&lt; 1%</td>
<td rowspan="1" colspan="1">Low proliferative index gliomas</td>
</tr>
<tr>
<td rowspan="5" colspan="1">Angiocentric Glioma</td>
<td rowspan="1" colspan="1">IDH1 p.R132H</td>
<td rowspan="1" colspan="1">Negative</td>
<td rowspan="1" colspan="1">Astroblastoma, MN-1, altered</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">GFAP</td>
<td rowspan="1" colspan="1">Positive</td>
<td rowspan="1" colspan="1">Astrocytoma, IDH-mutant</td>
</tr>
<tr>
<td rowspan="1" colspan="1">EMA</td>
<td rowspan="1" colspan="1">Perinuclear dot-like</td>
<td rowspan="1" colspan="1">Astrocytoma, IDH-wild type</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Olig-2</td>
<td rowspan="1" colspan="1">Negative</td>
<td rowspan="1" colspan="1">Ependymoma</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Ki-67 Proliferation Index</td>
<td rowspan="1" colspan="1">&lt; 1–5% [<a href="#REF16" class="usa-link" aria-describedby="REF16">16</a>,<a href="#REF18" class="usa-link" aria-describedby="REF18">18</a>,<a href="#REF20" class="usa-link" aria-describedby="REF20">20</a>]</td>
<td rowspan="1" colspan="1">Low-grade glioma</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="6" colspan="1">Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY)</td>
<td rowspan="1" colspan="1">IDH1 p.R132H</td>
<td rowspan="1" colspan="1">Negative</td>
<td rowspan="1" colspan="1">Astroblastoma, MN-1, altered</td>
</tr>
<tr>
<td rowspan="1" colspan="1">GFAP</td>
<td rowspan="1" colspan="1">Positive</td>
<td rowspan="1" colspan="1">Astrocytoma, IDH-mutant</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Olig-2</td>
<td rowspan="1" colspan="1">Positive</td>
<td rowspan="1" colspan="1">Astrocytoma, IDH-wild type</td>
</tr>
<tr>
<td rowspan="1" colspan="1">CD34</td>
<td rowspan="1" colspan="1">Positive</td>
<td rowspan="1" colspan="1">Ependymoma</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">ATRX</td>
<td rowspan="1" colspan="1">Retained expression</td>
<td rowspan="1" colspan="1">ATRX-retained gliomas</td>
</tr>
<tr>
<td rowspan="1" colspan="1">BRAFp.V600E</td>
<td rowspan="1" colspan="1">Positive (in up to 54% of cases)[<a href="#REF19" class="usa-link" aria-describedby="REF19">19</a>, <a href="#REF45" class="usa-link" aria-describedby="REF45">45</a>-<a href="#REF48" class="usa-link" aria-describedby="REF48">48</a>]</td>
<td rowspan="1" colspan="1">BRAF-mutant low-grade gliomas</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="6" colspan="1">Diffuse Low-Grade Glioma, MAPK Pathway-Altered</td>
<td rowspan="1" colspan="1">IDH1 p.R132H</td>
<td rowspan="1" colspan="1">Negative</td>
<td rowspan="1" colspan="1">Pilocytic astrocytoma</td>
</tr>
<tr>
<td rowspan="1" colspan="1">GFAP</td>
<td rowspan="1" colspan="1">Positive</td>
<td rowspan="1" colspan="1">DNET </td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Olig-2</td>
<td rowspan="1" colspan="1">Positive</td>
<td rowspan="1" colspan="1">Ganglioglioma</td>
</tr>
<tr>
<td rowspan="1" colspan="1">BRAFp.V600E</td>
<td rowspan="1" colspan="1">Positive</td>
<td rowspan="1" colspan="1">BRAF-driven tumors</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">H3F3A G34R/V</td>
<td rowspan="1" colspan="1">Negative</td>
<td rowspan="1" colspan="1">Excludes G34R/V mutant gliomas</td>
</tr>
<tr>
<td rowspan="1" colspan="1">H3K27M</td>
<td rowspan="1" colspan="1">Negative</td>
<td rowspan="1" colspan="1">Excludes midline glioma, H3K27-altered</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="FIG4"><h3 class="obj_head">Figure 4. Diffuse glioma, MAPK-pathway altered.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372413_cureus-0017-00000088575-i04.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f37/12372413/5b1dc2a0b3b2/cureus-0017-00000088575-i04.jpg" loading="lazy" height="1125" width="750" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/FIG4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) MRI shows a subcortical lesion with inhomogeneous signal and poorly defined margins. (B) Histology reveals neoplastic astrocytes entrapping cortical neurons and containing microcalcifications (H&amp;E, 10x). (C) GFAP immunostaining demonstrates strong positivity (GFAP, ×20). (D) BRAFV600E immunoreactivity is present in tumor cells (BRAF, 20x).</p>
<p>Image Source: Fabbri et al. [<a href="#REF40" class="usa-link" aria-describedby="REF40">40</a>] shared under the under a CC-BY-NC-ND 4.0 International License.</p>
<p>MRI: Magnetic resonance imaging; GFAP: Glial fibrillary acidic protein</p></figcaption></figure><p>Conventional therapeutic strategies for pediatric-type diffuse low-grade gliomas</p>
<p>Tumor resection proves to be an effective treatment for almost all circumscribed astrocytic gliomas, conferring an excellent prognosis with a minimal recurrence rate [<a href="#REF49" class="usa-link" aria-describedby="REF49">49</a>,<a href="#REF50" class="usa-link" aria-describedby="REF50">50</a>]. However, with pediatric-type diffuse low-grade gliomas, achieving clear surgical margins is not always possible, and hence adjuvant chemoradiation is the treatment of choice (especially for tumors occurring in deep-seated cortex or the midline structures). Surgical outcomes depend upon various factors, including the degree of infiltration of the tumor, its location in the cortex, and histologic grade. Grade II/ Diffuse pediatric gliomas that are located in deeper cortex or involve midline structures pose a significant surgical challenge [<a href="#REF51" class="usa-link" aria-describedby="REF51">51</a>,<a href="#REF52" class="usa-link" aria-describedby="REF52">52</a>].</p>
<p>Complete resection may not be achievable due to the infiltrative nature of these tumors and their frequent involvement of eloquent or inaccessible brain regions. Approved initial chemotherapy regimens include carboplatin and vincristine (CV); four-agent therapy including thioguanine, procarbazine, lomustine, and vincristine (TPCV); vinblastine alone therapy; and carboplatin monotherapy [<a href="#REF53" class="usa-link" aria-describedby="REF53">53</a>-<a href="#REF55" class="usa-link" aria-describedby="REF55">55</a>]. Secondary malignancy, liver dysfunction, bone marrow failure, anaphylactic shock, and other allergies are noteworthy side effects of chemotherapy [<a href="#REF53" class="usa-link" aria-describedby="REF53">53</a>, <a href="#REF56" class="usa-link" aria-describedby="REF56">56</a>].</p>
<p>Radiotherapy</p>
<p>Adjuvant radiotherapy, along with the cytotoxic conventional chemotherapy, had long been a standard of care for patients with recurrent or partially resected gliomas [<a href="#REF57" class="usa-link" aria-describedby="REF57">57</a>-<a href="#REF60" class="usa-link" aria-describedby="REF60">60</a>]. Unfortunately, conventional radiotherapy has caused several neurocognitive sequelae [<a href="#REF61" class="usa-link" aria-describedby="REF61">61</a>-<a href="#REF64" class="usa-link" aria-describedby="REF64">64</a>]. Recently, proton beam radiotherapy and stereotactically guided conformal radiotherapy have shown promising results concerning the safety profile [<a href="#REF59" class="usa-link" aria-describedby="REF59">59</a>,<a href="#REF60" class="usa-link" aria-describedby="REF60">60</a>] (Table <a href="#TAB2" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="TAB2"><h3 class="obj_head">Table 2. Molecular profile and therapeutic modalities for the treatment of pediatric-type diffuse low-grade gliomas.</h3>
<div class="caption p"><p>MYB: V-myb avian myeloblastosis viral oncogene homolog; MYBL1: V-myb avian myeloblastosis viral oncogene homolog-like 1; QKI: QKI, KH domain containing RNA binding); PCDHGA1: Protocadherin gamma subfamily A, 1; MMP16: Matrix metallopeptidase 16; MME: Membrane metalloendopeptidase; MAML2: Mastermind-like transcriptional coactivator 2; LOC105378099: an RNA gene, affiliated with the ncRNA class [<a href="#REF56" class="usa-link" aria-describedby="REF56">56</a>]; BRAFp.V600E: BRAF proto-oncogene, serine/threonine kinase, V600E refers to a specific mutation; FGFR: Fibroblast growth factor receptor; KIAA1549 (a protein-coding gene in <em>Homo sapiens</em>; SHTN1: Shootin 1; INA: Internexin neuronal intermediate filament protein alpha; TACC3: Transforming acidic coiled-coil containing protein 3; CTNNA3: Catenin alpha 3; FGFR(TKD)ITD: Fibroblast growth factor receptor tyrosine-kinase domain internal tandem duplications; NTRK: Neurotrophic tyrosine receptor kinase; MET: MET proto-oncogene, receptor tyrosine kinase; MAP2K1: Mitogen-activated protein kinase kinase 1; MEK: Mitogen-activated protein kinase kinase; mTOR: Mammalian target of rapamycin; AZD4547: An inhibitor of the FGFR family; LOC154902: Rare fusion partner of MYB gene in diffuse astrocytoma, MYB/MYBL1-altered [<a href="#REF73" class="usa-link" aria-describedby="REF73">73</a>]. </p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Tumor type</td>
<td rowspan="1" colspan="1">Molecular profile</td>
<td rowspan="1" colspan="1">Conventional treatment</td>
<td rowspan="1" colspan="1"> Emerging therapies</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Diffuse astrocytoma, MYB/MYBL1- Altered diffuse astrocytoma, MYB or MYBL1 altered</td>
<td rowspan="1" colspan="1">MYB/MYBL1 alterations (amplifications &amp; gene fusions), fusion partners (QKI, PCDHGA1, MMP16, MME, MAML2, LOC105378099, LOC154902)</td>
<td rowspan="1" colspan="1">Gross total resection / maximum safe resection, focal radiotherapy, adjuvant conventional chemotherapy.</td>
<td rowspan="1" colspan="1">MEK Inhibitors (trametinib, selumetinib) (<a href="https://clinicaltrials.gov/ct2/show/NCT03363217" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03363217</a>), mTOR inhibitors, MYB-targeted therapies [<a href="#REF65" class="usa-link" aria-describedby="REF65">65</a>-<a href="#REF67" class="usa-link" aria-describedby="REF67">67</a>]</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Angiocentric glioma  </td>
<td rowspan="1" colspan="1">MYB::QKI gene fusion [<a href="#REF68" class="usa-link" aria-describedby="REF68">68</a>-<a href="#REF71" class="usa-link" aria-describedby="REF71">71</a>]</td>
<td rowspan="1" colspan="1">Gross total resection / maximum safe resection.</td>
<td rowspan="1" colspan="1">MEK inhibitors (trametinib, selumetinib) (<a href="https://clinicaltrials.gov/ct2/show/NCT03363217" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03363217</a>)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Polymorphous low-grade neuroepithelial tumor of the young    </td>
<td rowspan="1" colspan="1">BRAFp.V600E &amp; FGFR mutations (FGFR2, FGFR3), fusions (KIAA1549::BRAF, FGFR2: SHTN1, FGFR2: INA and FGFR3: TACC3, FGFR: CTNNA3)</td>
<td rowspan="1" colspan="1">Gross total resection, subtotal resection [<a href="#REF19" class="usa-link" aria-describedby="REF19">19</a>]  </td>
<td rowspan="1" colspan="1">BRAF inhibitors (vemurafenib, dabrafenib) FGFR inhibitors (erdafitinib, AZD4547) [<a href="#REF72" class="usa-link" aria-describedby="REF72">72</a>-<a href="#REF74" class="usa-link" aria-describedby="REF74">74</a>]</td>
</tr>
<tr style="background-color:#ccc">
<td rowspan="1" colspan="1">Diffuse low-grade glioma, MAPK pathway-altered               </td>
<td rowspan="1" colspan="1">BRAFp.V600E mutations, FGFR1 (TKD) duplications, FGFR1 hotspot mutations, NTRK1/2/3, MET, FGFR2 &amp; MAP2K1 mutations.</td>
<td rowspan="1" colspan="1">Gross total resection, selective total resection.                                               </td>
<td rowspan="1" colspan="1">BRAF inhibitors (trametinib, dabrafenib), MEK inhibitors (selumetinib), FGFR inhibitors (erdafitinib)      </td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/TAB2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Limitations</p>
<p>Stereotactically-guided radiotherapy and proton beam radiotherapy are not yet widely accessible due to financial constraints and the requirement for specialized expertise. With the inevitable advancement in molecular pathology, several molecular targets have been identified, paving the way for the exploration of small-molecule inhibitors that cause fewer cytotoxic and radiotherapy-related adverse effects. This progress has led to numerous ongoing clinical trials and even the approval of several FDA-sanctioned targeted therapies for the treatment of recurrent, inoperable diffuse pediatric gliomas.</p>
<p>Proposed risk stratification model and treatment algorithm</p>
<p>Ryall et al. developed a comprehensive risk stratification model that incorporates patient age, tumor location, histopathologic features, and molecular profile. According to this model, pediatric gliomas are divided into three categories, namely low-risk, intermediate risk, and high risk, depending on the total score obtained after considering the above-mentioned clinical variables. Patients with a total score of (3-4 points) are treated conservatively, where they undergo gross total resection and subsequent observation (watchful waiting). Individuals with a score of 5-6 points are managed proactively through a combination of maximum safe or gross total resection, followed by conventional chemotherapy or targeted therapies. Careful close surveillance is done to detect any recurrence or aggressive behavior. Finally, high-risk patients with a total score of 7+ points are managed aggressively utilizing all possible therapeutic modalities, including maximum safe resection, multimodal conventional chemotherapeutic agents, and are subsequently enrolled in various clinical trials [<a href="#REF73" class="usa-link" aria-describedby="REF73">73</a>].</p></section><section id="sec3"><h2 class="pmc_sec_title">Conclusions</h2>
<p>In a nutshell, surgery remains the mainstay treatment for pediatric-type diffuse gliomas. However, not all tumors are located superficially, making their gross total resection tedious and, in certain instances, unachievable. In the past, various alternative therapeutic strategies had been employed to deal with recurrent and irresectable tumors, including conventional chemotherapy and radiotherapy, each of which has its own limitations and neurologic sequelae. With the advent of advanced ancillary techniques (immunohistochemistry, fluorescence in situ hybridization, droplet digital PCR, next generation sequencing, single-nucleotide polymorphism array, and nanostring ncounter and array methylation), precise molecular targets have been identified, opening a gateway to precision medicine and small molecule-based targeted therapy. There are, however, limitations in our knowledge regarding the adverse effects of new targeted therapies, raising serious concerns about their safety profiles and long-term patient outcomes. Numerous clinical trials are underway and are likely to provide a detailed account of the safety profile and feasibility of these yet enigmatic targeted therapies. Moving forward, a multidisciplinary approach combining molecular diagnostics, clinical acumen, and long-term follow-up will be essential to optimize treatment strategies and improve prognostic outcomes for pediatric patients with diffuse low-grade gliomas.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>Some portions of the language editing and refinement of this manuscript were assisted by artificial intelligence (AI) tools, including ChatGPT by OpenAI, to enhance clarity and coherence.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Disclosures</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Conflicts of interest:</strong> In compliance with the ICMJE uniform disclosure form, all authors declare the following:</p>
<p><strong>Payment/services info:</strong> All authors have declared that no financial support was received from any organization for the submitted work.</p>
<p><strong>Financial relationships:</strong> All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.</p>
<p><strong>Other relationships:</strong> All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p>
</div></div></section><section id="fn-group2" class="fn-group"><h2 class="pmc_sec_title">Author Contributions</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn2">
<p><strong>Concept and design:</strong>  Abeer Javed</p>
<p><strong>Acquisition, analysis, or interpretation of data:</strong>  Abeer Javed</p>
<p><strong>Drafting of the manuscript:</strong>  Abeer Javed</p>
<p><strong>Critical review of the manuscript for important intellectual content:</strong>  Abeer Javed</p>
<p><strong>Supervision:</strong>  Abeer Javed</p>
</div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="REF1">
<span class="label">1.</span><cite>CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Ostrom QT, Price M, Ryan K, et al.  Neuro Oncol. 2022;24:0. doi: 10.1093/neuonc/noac161.</cite> [<a href="https://doi.org/10.1093/neuonc/noac161" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9447434/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36066969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=CBTRUS%20statistical%20report:%20pediatric%20brain%20tumor%20foundation%20childhood%20and%20adolescent%20primary%20brain%20and%20other%20central%20nervous%20system%20tumors%20diagnosed%20in%20the%20United%20States%20in%202014-2018&amp;volume=24&amp;publication_year=2022&amp;pages=0&amp;pmid=36066969&amp;doi=10.1093/neuonc/noac161&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF2">
<span class="label">2.</span><cite>Successful retreatment of a child with a refractory brainstem ganglioglioma with vemurafenib. Aguilera D, Janss A, Mazewski C, et al.  Pediatr Blood Cancer. 2016;63:541–543. doi: 10.1002/pbc.25787.</cite> [<a href="https://doi.org/10.1002/pbc.25787" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26579623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr%20Blood%20Cancer&amp;title=Successful%20retreatment%20of%20a%20child%20with%20a%20refractory%20brainstem%20ganglioglioma%20with%20vemurafenib&amp;volume=63&amp;publication_year=2016&amp;pages=541-543&amp;pmid=26579623&amp;doi=10.1002/pbc.25787&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF3">
<span class="label">3.</span><cite>Alex's Lemonade Stand Foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Ostrom QT, de Blank PM, Kruchko C, et al.  Neuro Oncol. 2015;16:1–36. doi: 10.1093/neuonc/nou327.</cite> [<a href="https://doi.org/10.1093/neuonc/nou327" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4277295/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25542864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=Alex's%20Lemonade%20Stand%20Foundation%20infant%20and%20childhood%20primary%20brain%20and%20central%20nervous%20system%20tumors%20diagnosed%20in%20the%20United%20States%20in%202007-2011&amp;volume=16&amp;publication_year=2015&amp;pages=1-36&amp;pmid=25542864&amp;doi=10.1093/neuonc/nou327&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF4">
<span class="label">4.</span><cite>Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases. Aisner DL, Newell KL, Pollack AG, Kleinschmidt-Demasters BK, Steinberg GK, Smyth LT, Vogel H. Clin Neuropathol. 2014;33:112–121. doi: 10.5414/NP300679.</cite> [<a href="https://doi.org/10.5414/NP300679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4594433/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24321241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Neuropathol&amp;title=Composite%20pleomorphic%20xanthoastrocytoma-epithelioid%20glioneuronal%20tumor%20with%20BRAF%20V600E%20mutation%20-%20report%20of%20three%20cases&amp;volume=33&amp;publication_year=2014&amp;pages=112-121&amp;pmid=24321241&amp;doi=10.5414/NP300679&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF5">
<span class="label">5.</span><cite>Pediatric gliomas: current concepts on diagnosis, biology, and clinical management. Sturm D, Pfister SM, Jones DT. J Clin Oncol. 2017;35:2370–2377. doi: 10.1200/JCO.2017.73.0242.</cite> [<a href="https://doi.org/10.1200/JCO.2017.73.0242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28640698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Pediatric%20gliomas:%20current%20concepts%20on%20diagnosis,%20biology,%20and%20clinical%20management&amp;volume=35&amp;publication_year=2017&amp;pages=2370-2377&amp;pmid=28640698&amp;doi=10.1200/JCO.2017.73.0242&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF6">
<span class="label">6.</span><cite>The 2007 WHO classification of tumours of the central nervous system. Louis DN, Ohgaki H, Wiestler OD, et al.  Acta Neuropathol. 2007;114:97–109. doi: 10.1007/s00401-007-0243-4.</cite> [<a href="https://doi.org/10.1007/s00401-007-0243-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1929165/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17618441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol&amp;title=The%202007%20WHO%20classification%20of%20tumours%20of%20the%20central%20nervous%20system&amp;volume=114&amp;publication_year=2007&amp;pages=97-109&amp;pmid=17618441&amp;doi=10.1007/s00401-007-0243-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF7">
<span class="label">7.</span><cite>International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Louis DN, Perry A, Burger P, et al.  Brain Pathol. 2014;24:429–435. doi: 10.1111/bpa.12171.</cite> [<a href="https://doi.org/10.1111/bpa.12171" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8029490/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24990071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Pathol&amp;title=International%20Society%20Of%20Neuropathology--Haarlem%20consensus%20guidelines%20for%20nervous%20system%20tumor%20classification%20and%20grading&amp;volume=24&amp;publication_year=2014&amp;pages=429-435&amp;pmid=24990071&amp;doi=10.1111/bpa.12171&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF8">
<span class="label">8.</span><cite>A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment. Ryall S, Tabori U, Hawkins C. Brain Tumor Pathol. 2017;34:51–61. doi: 10.1007/s10014-017-0282-z.</cite> [<a href="https://doi.org/10.1007/s10014-017-0282-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28342104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Tumor%20Pathol&amp;title=A%20comprehensive%20review%20of%20paediatric%20low-grade%20diffuse%20glioma:%20pathology,%20molecular%20genetics%20and%20treatment&amp;volume=34&amp;publication_year=2017&amp;pages=51-61&amp;pmid=28342104&amp;doi=10.1007/s10014-017-0282-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF9">
<span class="label">9.</span><cite>IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age. Ferris SP, Goode B, Joseph NM, et al.  Acta Neuropathol. 2016;132:153–155. doi: 10.1007/s00401-016-1579-4.</cite> [<a href="https://doi.org/10.1007/s00401-016-1579-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4915961/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27161253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol&amp;title=IDH1%20mutation%20can%20be%20present%20in%20diffuse%20astrocytomas%20and%20giant%20cell%20glioblastomas%20of%20young%20children%20under%2010%20years%20of%20age&amp;volume=132&amp;publication_year=2016&amp;pages=153-155&amp;pmid=27161253&amp;doi=10.1007/s00401-016-1579-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF10">
<span class="label">10.</span><cite>cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Louis DN, Giannini C, Capper D, et al.  Acta Neuropathol. 2018;135:639–642. doi: 10.1007/s00401-018-1826-y.</cite> [<a href="https://doi.org/10.1007/s00401-018-1826-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29497819/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol&amp;title=cIMPACT-NOW%20update%202:%20diagnostic%20clarifications%20for%20diffuse%20midline%20glioma,%20H3%20K27M-mutant%20and%20diffuse%20astrocytoma/anaplastic%20astrocytoma,%20IDH-mutant&amp;volume=135&amp;publication_year=2018&amp;pages=639-642&amp;pmid=29497819&amp;doi=10.1007/s00401-018-1826-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF11">
<span class="label">11.</span><cite>cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF(V600E) mutation. Ellison DW, Hawkins C, Jones DT, Onar-Thomas A, Pfister SM, Reifenberger G, Louis DN. Acta Neuropathol. 2019;137:683–687. doi: 10.1007/s00401-019-01987-0.</cite> [<a href="https://doi.org/10.1007/s00401-019-01987-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30848347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol&amp;title=cIMPACT-NOW%20update%204:%20diffuse%20gliomas%20characterized%20by%20MYB,%20MYBL1,%20or%20FGFR1%20alterations%20or%20BRAF(V600E)%20mutation&amp;volume=137&amp;publication_year=2019&amp;pages=683-687&amp;pmid=30848347&amp;doi=10.1007/s00401-019-01987-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF12">
<span class="label">12.</span><cite>Surgical neuropathology of focal epilepsies: textbook and atlas. Lehman NL. J Neuropathol Exp Neurol. 2016;75:291. doi: 10.1093/jnen/nlw006.</cite> [<a href="https://doi.org/10.1093/jnen/nlw006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7299432/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26912671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neuropathol%20Exp%20Neurol&amp;title=Surgical%20neuropathology%20of%20focal%20epilepsies:%20textbook%20and%20atlas&amp;volume=75&amp;publication_year=2016&amp;pages=291&amp;pmid=26912671&amp;doi=10.1093/jnen/nlw006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF13">
<span class="label">13.</span><cite>Isomorphic diffuse glioma has recurrent gene fusions of MYBL1 or MYB and can be distinguished from other MYB/MYBL1 altered gliomas based on a distinct morphology and DNA methylation profile. Wefers AK, Stichel D, Schrimpf D, et al.  Neuro Oncol. 2020;22:0–3.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=Isomorphic%20diffuse%20glioma%20has%20recurrent%20gene%20fusions%20of%20MYBL1%20or%20MYB%20and%20can%20be%20distinguished%20from%20other%20MYB/MYBL1%20altered%20gliomas%20based%20on%20a%20distinct%20morphology%20and%20DNA%20methylation%20profile&amp;volume=22&amp;publication_year=2020&amp;pages=0-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF14">
<span class="label">14.</span><cite>A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. Chiang J, Harreld JH, Tinkle CL, et al.  Acta Neuropathol. 2019;138:1091–1092. doi: 10.1007/s00401-019-02081-1.</cite> [<a href="https://doi.org/10.1007/s00401-019-02081-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7467132/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31595312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol&amp;title=A%20single-center%20study%20of%20the%20clinicopathologic%20correlates%20of%20gliomas%20with%20a%20MYB%20or%20MYBL1%20alteration&amp;volume=138&amp;publication_year=2019&amp;pages=1091-1092&amp;pmid=31595312&amp;doi=10.1007/s00401-019-02081-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF15">
<span class="label">15.</span><cite>Newly recognized CNS tumors in the 2021 World Health Organization classification: imaging overview with histopathologic and genetic correlation. Rigsby RK, Brahmbhatt P, Desai AB, et al.  AJNR Am J Neuroradiol. 2023;44:367–380. doi: 10.3174/ajnr.A7827.</cite> [<a href="https://doi.org/10.3174/ajnr.A7827" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10084895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36997287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AJNR%20Am%20J%20Neuroradiol&amp;title=Newly%20recognized%20CNS%20tumors%20in%20the%202021%20World%20Health%20Organization%20classification:%20imaging%20overview%20with%20histopathologic%20and%20genetic%20correlation&amp;volume=44&amp;publication_year=2023&amp;pages=367-380&amp;pmid=36997287&amp;doi=10.3174/ajnr.A7827&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF16">
<span class="label">16.</span><cite>Pediatric angiocentric glioma with acute intracerebral hemorrhage: a case report with 36 months follow-up. Zhang R, Xu X, Zhou H, Yao D, Wei R, Muhammad S. Surg Neurol Int. 2021;12:499. doi: 10.25259/SNI_791_2021.</cite> [<a href="https://doi.org/10.25259/SNI_791_2021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8571264/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34754549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Surg%20Neurol%20Int&amp;title=Pediatric%20angiocentric%20glioma%20with%20acute%20intracerebral%20hemorrhage:%20a%20case%20report%20with%2036%20months%20follow-up&amp;volume=12&amp;publication_year=2021&amp;pages=499&amp;pmid=34754549&amp;doi=10.25259/SNI_791_2021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF17">
<span class="label">17.</span><cite>Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma. Moreira DC, Qaddoumi I, Spiller S, et al.  Neuro Oncol. 2024;26:1327–1334. doi: 10.1093/neuonc/noae048.</cite> [<a href="https://doi.org/10.1093/neuonc/noae048" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11226882/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38466086/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=Comprehensive%20analysis%20of%20MYB/MYBL1-altered%20pediatric-type%20diffuse%20low-grade%20glioma&amp;volume=26&amp;publication_year=2024&amp;pages=1327-1334&amp;pmid=38466086&amp;doi=10.1093/neuonc/noae048&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF18">
<span class="label">18.</span><cite>Angiocentric neuroepithelial tumor (ANET): a new epilepsy-related clinicopathological entity with distinctive MRI. Lellouch-Tubiana A, Boddaert N, Bourgeois M, et al.  Brain Pathol. 2005;15:281–286. doi: 10.1111/j.1750-3639.2005.tb00112.x.</cite> [<a href="https://doi.org/10.1111/j.1750-3639.2005.tb00112.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8095937/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16389940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Pathol&amp;title=Angiocentric%20neuroepithelial%20tumor%20(ANET):%20a%20new%20epilepsy-related%20clinicopathological%20entity%20with%20distinctive%20MRI&amp;volume=15&amp;publication_year=2005&amp;pages=281-286&amp;pmid=16389940&amp;doi=10.1111/j.1750-3639.2005.tb00112.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF19">
<span class="label">19.</span><cite>Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma. Wang M, Tihan T, Rojiani AM, et al.  J Neuropathol Exp Neurol. 2005;64:875–881. doi: 10.1097/01.jnen.0000182981.02355.10.</cite> [<a href="https://doi.org/10.1097/01.jnen.0000182981.02355.10" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16215459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neuropathol%20Exp%20Neurol&amp;title=Monomorphous%20angiocentric%20glioma:%20a%20distinctive%20epileptogenic%20neoplasm%20with%20features%20of%20infiltrating%20astrocytoma%20and%20ependymoma&amp;volume=64&amp;publication_year=2005&amp;pages=875-881&amp;pmid=16215459&amp;doi=10.1097/01.jnen.0000182981.02355.10&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF20">
<span class="label">20.</span><cite>Angiocentric glioma: a clinicopathologic review of 5 tumors with identification of associated cortical dysplasia. Marburger T, Prayson R. Arch Pathol Lab Med. 2011;135:1037–1041. doi: 10.5858/2010-0668-OAR.</cite> [<a href="https://doi.org/10.5858/2010-0668-OAR" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21809996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Pathol%20Lab%20Med&amp;title=Angiocentric%20glioma:%20a%20clinicopathologic%20review%20of%205%20tumors%20with%20identification%20of%20associated%20cortical%20dysplasia&amp;volume=135&amp;publication_year=2011&amp;pages=1037-1041&amp;pmid=21809996&amp;doi=10.5858/2010-0668-OAR&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF21">
<span class="label">21.</span><cite>Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Huse JT, Snuderl M, Jones DT, et al.  Acta Neuropathol. 2017;133:417–429. doi: 10.1007/s00401-016-1639-9.</cite> [<a href="https://doi.org/10.1007/s00401-016-1639-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5325850/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27812792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol&amp;title=Polymorphous%20low-grade%20neuroepithelial%20tumor%20of%20the%20young%20(PLNTY):%20an%20epileptogenic%20neoplasm%20with%20oligodendroglioma-like%20components,%20aberrant%20CD34%20expression,%20and%20genetic%20alterations%20involving%20the%20MAP%20kinase%20pathway&amp;volume=133&amp;publication_year=2017&amp;pages=417-429&amp;pmid=27812792&amp;doi=10.1007/s00401-016-1639-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF22">
<span class="label">22.</span><cite>Imaging characteristics of an unusual, high-grade angiocentric glioma: a case report and review of the literature. Aguilar HN, Hung RW, Mehta V, Kotylak T. J Radiol Case Rep. 2012;6:1. doi: 10.3941/jrcr.v6i10.1134.</cite> [<a href="https://doi.org/10.3941/jrcr.v6i10.1134" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3558271/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23378871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Radiol%20Case%20Rep&amp;title=Imaging%20characteristics%20of%20an%20unusual,%20high-grade%20angiocentric%20glioma:%20a%20case%20report%20and%20review%20of%20the%20literature&amp;volume=6&amp;publication_year=2012&amp;pages=1&amp;pmid=23378871&amp;doi=10.3941/jrcr.v6i10.1134&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF23">
<span class="label">23.</span><cite>Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases. Preusser M, Hoischen A, Novak K, et al.  Am J Surg Pathol. 2007;31:1709–1718. doi: 10.1097/PAS.0b013e31804a7ebb.</cite> [<a href="https://doi.org/10.1097/PAS.0b013e31804a7ebb" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18059228/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Surg%20Pathol&amp;title=Angiocentric%20glioma:%20report%20of%20clinico-pathologic%20and%20genetic%20findings%20in%208%20cases&amp;volume=31&amp;publication_year=2007&amp;pages=1709-1718&amp;pmid=18059228&amp;doi=10.1097/PAS.0b013e31804a7ebb&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF24">
<span class="label">24.</span><cite>Novel chromosomal rearrangements and break points at the t (6; 9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Mitani Y, Rao PH, Futreal PA, et al.  Clin Cancer Res. 2011;17:7003–7014. doi: 10.1158/1078-0432.CCR-11-1870.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-11-1870" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3225955/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21976542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Novel%20chromosomal%20rearrangements%20and%20break%20points%20at%20the%20t%20(6;%209)%20in%20salivary%20adenoid%20cystic%20carcinoma:%20association%20with%20MYB-NFIB%20chimeric%20fusion,%20MYB%20expression,%20and%20clinical%20outcome&amp;volume=17&amp;publication_year=2011&amp;pages=7003-7014&amp;pmid=21976542&amp;doi=10.1158/1078-0432.CCR-11-1870&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF25">
<span class="label">25.</span><cite>LG-02: MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Bergthold G, Bandopadhayay P, Ramkissoon L, et al.  Neuro Oncol. 2016;18:0. doi: 10.1038/ng.3500.</cite> [<a href="https://doi.org/10.1038/ng.3500" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4767685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26829751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=LG-02:%20MYB-QKI%20rearrangements%20in%20angiocentric%20glioma%20drive%20tumorigenicity%20through%20a%20tripartite%20mechanism&amp;volume=18&amp;publication_year=2016&amp;pages=0&amp;pmid=26829751&amp;doi=10.1038/ng.3500&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF26">
<span class="label">26.</span><cite>DNA methylation and histone modification in low-grade gliomas: current understanding and potential clinical targets. Ozair A, Bhat V, Alisch RS, et al.  Cancers. 2023;15:1342. doi: 10.3390/cancers15041342.</cite> [<a href="https://doi.org/10.3390/cancers15041342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9954183/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36831683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=DNA%20methylation%20and%20histone%20modification%20in%20low-grade%20gliomas:%20current%20understanding%20and%20potential%20clinical%20targets&amp;volume=15&amp;publication_year=2023&amp;pages=1342&amp;pmid=36831683&amp;doi=10.3390/cancers15041342&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF27">
<span class="label">27.</span><cite>Angiocentric glioma of brainstem. Almubarak AO, Alahmari A, Al Hindi H, AlShail E. Neurosciences (Riyadh) 2020;25:416–420. doi: 10.17712/nsj.2020.5.20200026.</cite> [<a href="https://doi.org/10.17712/nsj.2020.5.20200026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8015589/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33459294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurosciences%20(Riyadh)&amp;title=Angiocentric%20glioma%20of%20brainstem&amp;volume=25&amp;publication_year=2020&amp;pages=416-420&amp;pmid=33459294&amp;doi=10.17712/nsj.2020.5.20200026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF28">
<span class="label">28.</span><cite>Multi-platform classification of IDH-wild-type glioblastoma based on ERK/MAPK pathway: diagnostic, prognostic and therapeutic implications. Georgescu M-M. Cancers. 2021;13:4532. doi: 10.3390/cancers13184532.</cite> [<a href="https://doi.org/10.3390/cancers13184532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8470497/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34572759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Multi-platform%20classification%20of%20IDH-wild-type%20glioblastoma%20based%20on%20ERK/MAPK%20pathway:%20diagnostic,%20prognostic%20and%20therapeutic%20implications&amp;volume=13&amp;publication_year=2021&amp;pages=4532&amp;pmid=34572759&amp;doi=10.3390/cancers13184532&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF29">
<span class="label">29.</span><cite>Rapid progression of an IDH-wild type histological low-grade glioma harbouring TERT promoter mutation and diffuse CD34 expression: a case report. Wang H, Tan C, Xu T, Li W. Folia Neuropathol. 2021;59:104–111. doi: 10.5114/fn.2021.104471.</cite> [<a href="https://doi.org/10.5114/fn.2021.104471" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33969682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Folia%20Neuropathol&amp;title=Rapid%20progression%20of%20an%20IDH-wild%20type%20histological%20low-grade%20glioma%20harbouring%20TERT%20promoter%20mutation%20and%20diffuse%20CD34%20expression:%20a%20case%20report&amp;volume=59&amp;publication_year=2021&amp;pages=104-111&amp;pmid=33969682&amp;doi=10.5114/fn.2021.104471&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF30">
<span class="label">30.</span><cite>Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma. Yadav V, Zhang X, Liu J, et al.  J Biol Chem. 2012;287:28087–28098. doi: 10.1074/jbc.M112.377218.</cite> [<a href="https://doi.org/10.1074/jbc.M112.377218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3431627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22730329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=Reactivation%20of%20mitogen-activated%20protein%20kinase%20(MAPK)%20pathway%20by%20FGF%20receptor%203%20(FGFR3)/Ras%20mediates%20resistance%20to%20vemurafenib%20in%20human%20B-RAF%20V600E%20mutant%20melanoma&amp;volume=287&amp;publication_year=2012&amp;pages=28087-28098&amp;pmid=22730329&amp;doi=10.1074/jbc.M112.377218&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF31">
<span class="label">31.</span><cite>Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): scoping review of case reports and case series. Singh D, Joshi VP, Pattankar S, et al.  Asian J Neurosurg. 2024;19:126–136. doi: 10.1055/s-0044-1786700.</cite> [<a href="https://doi.org/10.1055/s-0044-1786700" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11226258/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38974443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20J%20Neurosurg&amp;title=Polymorphous%20low-grade%20neuroepithelial%20tumor%20of%20the%20young%20(PLNTY):%20scoping%20review%20of%20case%20reports%20and%20case%20series&amp;volume=19&amp;publication_year=2024&amp;pages=126-136&amp;pmid=38974443&amp;doi=10.1055/s-0044-1786700&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF32">
<span class="label">32.</span><cite>Reversible splenial lesion syndrome in children: retrospective study and summary of case series. Chen W-X, Liu H-S, Yang S-D, et al.  Brain Dev. 2016;38:915–927. doi: 10.1016/j.braindev.2016.04.011.</cite> [<a href="https://doi.org/10.1016/j.braindev.2016.04.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27591118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Dev&amp;title=Reversible%20splenial%20lesion%20syndrome%20in%20children:%20retrospective%20study%20and%20summary%20of%20case%20series&amp;volume=38&amp;publication_year=2016&amp;pages=915-927&amp;pmid=27591118&amp;doi=10.1016/j.braindev.2016.04.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF33">
<span class="label">33.</span><cite>Plenty of calcification: imaging characterization of polymorphous low-grade neuroepithelial tumor of the young. Johnson DR, Giannini C, Jenkins RB, Kim DK, Kaufmann TJ. Neuroradiology. 2019;61:1327–1332. doi: 10.1007/s00234-019-02269-y.</cite> [<a href="https://doi.org/10.1007/s00234-019-02269-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31396664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroradiology&amp;title=Plenty%20of%20calcification:%20imaging%20characterization%20of%20polymorphous%20low-grade%20neuroepithelial%20tumor%20of%20the%20young&amp;volume=61&amp;publication_year=2019&amp;pages=1327-1332&amp;pmid=31396664&amp;doi=10.1007/s00234-019-02269-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF34">
<span class="label">34.</span><cite>Neuroradiological features of the polymorphous low-grade neuroepithelial tumor of the young: five new cases with a systematic review of the literature. Kurokawa M, Kurokawa R, Capizzano AA, et al.  Neuroradiology. 2022;64:1255–1264. doi: 10.1007/s00234-021-02879-5.</cite> [<a href="https://doi.org/10.1007/s00234-021-02879-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35001164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroradiology&amp;title=Neuroradiological%20features%20of%20the%20polymorphous%20low-grade%20neuroepithelial%20tumor%20of%20the%20young:%20five%20new%20cases%20with%20a%20systematic%20review%20of%20the%20literature&amp;volume=64&amp;publication_year=2022&amp;pages=1255-1264&amp;pmid=35001164&amp;doi=10.1007/s00234-021-02879-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF35">
<span class="label">35.</span><cite>The 2021 WHO classification of tumors of the central nervous system: an update on pediatric low‐grade gliomas and glioneuronal tumors. Bale TA, Rosenblum MK. Brain Pathol. 2022;32:0. doi: 10.1111/bpa.13060.</cite> [<a href="https://doi.org/10.1111/bpa.13060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9245930/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35218102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Pathol&amp;title=The%202021%20WHO%20classification%20of%20tumors%20of%20the%20central%20nervous%20system:%20an%20update%20on%20pediatric%20low%E2%80%90grade%20gliomas%20and%20glioneuronal%20tumors&amp;volume=32&amp;publication_year=2022&amp;pages=0&amp;pmid=35218102&amp;doi=10.1111/bpa.13060&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF36">
<span class="label">36.</span><cite>Angiocentric glioma: a case report and review of the literature. Wang H, Zhu J, Zhu P, Luo C. J Clin Neurosci. 2021;94:179–185. doi: 10.1016/j.jocn.2021.10.016.</cite> [<a href="https://doi.org/10.1016/j.jocn.2021.10.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34863434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Neurosci&amp;title=Angiocentric%20glioma:%20a%20case%20report%20and%20review%20of%20the%20literature&amp;volume=94&amp;publication_year=2021&amp;pages=179-185&amp;pmid=34863434&amp;doi=10.1016/j.jocn.2021.10.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF37">
<span class="label">37.</span><cite>Clinical, radiological, pathological features and seizure outcome with surgical management of polymorphous low-grade neuroepithelial tumor of the young associated with epilepsy. Fei X, Zhao J, Wei W, et al.  Front Oncol. 2022;12:863373. doi: 10.3389/fonc.2022.863373.</cite> [<a href="https://doi.org/10.3389/fonc.2022.863373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8971723/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35372027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Clinical,%20radiological,%20pathological%20features%20and%20seizure%20outcome%20with%20surgical%20management%20of%20polymorphous%20low-grade%20neuroepithelial%20tumor%20of%20the%20young%20associated%20with%20epilepsy&amp;volume=12&amp;publication_year=2022&amp;pages=863373&amp;pmid=35372027&amp;doi=10.3389/fonc.2022.863373&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF38">
<span class="label">38.</span><cite>MAPK pathway alterations in polymorphous low-grade neuroepithelial tumor of the young: diagnostic considerations. Rao S, Goyal A, Johnson A, Sadashiva N, Kulanthaivelu K, Vazhayil V, Santosh V. Brain Tumor Pathol. 2024;41:109–116. doi: 10.1007/s10014-024-00487-8.</cite> [<a href="https://doi.org/10.1007/s10014-024-00487-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39154303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Tumor%20Pathol&amp;title=MAPK%20pathway%20alterations%20in%20polymorphous%20low-grade%20neuroepithelial%20tumor%20of%20the%20young:%20diagnostic%20considerations&amp;volume=41&amp;publication_year=2024&amp;pages=109-116&amp;pmid=39154303&amp;doi=10.1007/s10014-024-00487-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF39">
<span class="label">39.</span><cite>FGFR alterations in thyroid carcinoma: a novel class of primary drivers with significant therapeutic implications and secondary molecular events potentially mediating resistance in thyroid malignancy. Sabbagh MF, Janovitz T, Dias-Santagata D, et al.  Thyroid. 2024;34:1137–1149. doi: 10.1089/thy.2024.0216.</cite> [<a href="https://doi.org/10.1089/thy.2024.0216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39003525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thyroid&amp;title=FGFR%20alterations%20in%20thyroid%20carcinoma:%20a%20novel%20class%20of%20primary%20drivers%20with%20significant%20therapeutic%20implications%20and%20secondary%20molecular%20events%20potentially%20mediating%20resistance%20in%20thyroid%20malignancy&amp;volume=34&amp;publication_year=2024&amp;pages=1137-1149&amp;pmid=39003525&amp;doi=10.1089/thy.2024.0216&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF40">
<span class="label">40.</span><cite>Paediatric-type diffuse low-grade gliomas: a clinically and biologically distinct group of tumours with a favourable outcome. Fabbri VP, Caporalini C, Asioli S, Buccoliero A. Pathologica. 2022;114:410–421. doi: 10.32074/1591-951X-828.</cite> [<a href="https://doi.org/10.32074/1591-951X-828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9763978/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36534420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathologica&amp;title=Paediatric-type%20diffuse%20low-grade%20gliomas:%20a%20clinically%20and%20biologically%20distinct%20group%20of%20tumours%20with%20a%20favourable%20outcome&amp;volume=114&amp;publication_year=2022&amp;pages=410-421&amp;pmid=36534420&amp;doi=10.32074/1591-951X-828&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF41">
<span class="label">41.</span><cite>T2-FLAIR mismatch: an imaging biomarker for children’s MYB/MYBL1-altered diffuse astrocytoma or angiocentric glioma. Van Maren E, Dankbaar J, Wesseling P, et al.  Am J Neuroradiol. 2024;45:747–752. doi: 10.3174/ajnr.A8203.</cite> [<a href="https://doi.org/10.3174/ajnr.A8203" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11288608/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38724203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Neuroradiol&amp;title=T2-FLAIR%20mismatch:%20an%20imaging%20biomarker%20for%20children%E2%80%99s%20MYB/MYBL1-altered%20diffuse%20astrocytoma%20or%20angiocentric%20glioma&amp;volume=45&amp;publication_year=2024&amp;pages=747-752&amp;pmid=38724203&amp;doi=10.3174/ajnr.A8203&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF42">
<span class="label">42.</span><cite>Paediatric low-grade glioma: the role of classical pathology in integrated diagnostic practice. Stone TJ, Merve A, Valerio F, Yasin SA, Jacques TS. Childs Nerv Sys. 2024;40:3189–3207. doi: 10.1007/s00381-024-06591-6.</cite> [<a href="https://doi.org/10.1007/s00381-024-06591-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11511714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39294363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Childs%20Nerv%20Sys&amp;title=Paediatric%20low-grade%20glioma:%20the%20role%20of%20classical%20pathology%20in%20integrated%20diagnostic%20practice&amp;volume=40&amp;publication_year=2024&amp;pages=3189-3207&amp;pmid=39294363&amp;doi=10.1007/s00381-024-06591-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF43">
<span class="label">43.</span><cite>2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review. Thomas DL. Chin Clin Oncol. 2023;12:7. doi: 10.21037/cco-22-120.</cite> [<a href="https://doi.org/10.21037/cco-22-120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36922356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chin%20Clin%20Oncol&amp;title=2021%20updates%20to%20the%20World%20Health%20Organization%20classification%20of%20adult-type%20and%20pediatric-type%20diffuse%20gliomas:%20a%20clinical%20practice%20review&amp;volume=12&amp;publication_year=2023&amp;pages=7&amp;pmid=36922356&amp;doi=10.21037/cco-22-120&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF44">
<span class="label">44.</span><cite>The 2021 WHO classification of tumors of the central nervous system: a summary. Louis DN, Perry A, Wesseling P, et al.  Neuro Oncol. 2021;23:1231–1251. doi: 10.1093/neuonc/noab106.</cite> [<a href="https://doi.org/10.1093/neuonc/noab106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8328013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34185076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=The%202021%20WHO%20classification%20of%20tumors%20of%20the%20central%20nervous%20system:%20a%20summary&amp;volume=23&amp;publication_year=2021&amp;pages=1231-1251&amp;pmid=34185076&amp;doi=10.1093/neuonc/noab106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF45">
<span class="label">45.</span><cite>Case report of rarely described polymorphous low-grade neuroepithelial tumor of the young and comparison with oligodendroglioma. Sumdani H, Shahbuddin Z, Harper G, Hamilton L. World Neurosurg. 2019;127:47–51. doi: 10.1016/j.wneu.2019.03.181.</cite> [<a href="https://doi.org/10.1016/j.wneu.2019.03.181" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30926558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20Neurosurg&amp;title=Case%20report%20of%20rarely%20described%20polymorphous%20low-grade%20neuroepithelial%20tumor%20of%20the%20young%20and%20comparison%20with%20oligodendroglioma&amp;volume=127&amp;publication_year=2019&amp;pages=47-51&amp;pmid=30926558&amp;doi=10.1016/j.wneu.2019.03.181&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF46">
<span class="label">46.</span><cite>Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): genetic analysis confirms frequent MAPK pathway activation. Ida C, Johnson D, Kollmeyer T, et al.  Neuro Oncol. 2019;21:0. doi: 10.1093/jnen/nlab075.</cite> [<a href="https://doi.org/10.1093/jnen/nlab075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8921648/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34363682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=Polymorphous%20low-grade%20neuroepithelial%20tumor%20of%20the%20young%20(PLNTY):%20genetic%20analysis%20confirms%20frequent%20MAPK%20pathway%20activation&amp;volume=21&amp;publication_year=2019&amp;pages=0&amp;pmid=34363682&amp;doi=10.1093/jnen/nlab075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF47">
<span class="label">47.</span><cite>Polymorphous low-grade neuroepithelial tumor of the young: case report of a newly described histopathological entity. Lelotte J, Duprez T, Raftopoulos C, Michotte A. Acta Neurol Belg. 2020;120:729–732. doi: 10.1007/s13760-019-01241-0.</cite> [<a href="https://doi.org/10.1007/s13760-019-01241-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31754999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neurol%20Belg&amp;title=Polymorphous%20low-grade%20neuroepithelial%20tumor%20of%20the%20young:%20case%20report%20of%20a%20newly%20described%20histopathological%20entity&amp;volume=120&amp;publication_year=2020&amp;pages=729-732&amp;pmid=31754999&amp;doi=10.1007/s13760-019-01241-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF48">
<span class="label">48.</span><cite>Polymorphous low-grade neuroepithelial tumor of the young: a case report with genomic findings. Gupta VR, Giller C, Kolhe R, Forseen SE, Sharma S. World Neurosurg. 2019;132:347–355. doi: 10.1016/j.wneu.2019.08.221.</cite> [<a href="https://doi.org/10.1016/j.wneu.2019.08.221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31520766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20Neurosurg&amp;title=Polymorphous%20low-grade%20neuroepithelial%20tumor%20of%20the%20young:%20a%20case%20report%20with%20genomic%20findings&amp;volume=132&amp;publication_year=2019&amp;pages=347-355&amp;pmid=31520766&amp;doi=10.1016/j.wneu.2019.08.221&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF49">
<span class="label">49.</span><cite>Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children's Oncology Group. Wisoff JH, Sanford RA, Heier LA, et al.  Neurosurgery. 2011;68:1548–1554. doi: 10.1227/NEU.0b013e318214a66e.</cite> [<a href="https://doi.org/10.1227/NEU.0b013e318214a66e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21368693/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurosurgery&amp;title=Primary%20neurosurgery%20for%20pediatric%20low-grade%20gliomas:%20a%20prospective%20multi-institutional%20study%20from%20the%20Children's%20Oncology%20Group&amp;volume=68&amp;publication_year=2011&amp;pages=1548-1554&amp;pmid=21368693&amp;doi=10.1227/NEU.0b013e318214a66e&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF50">
<span class="label">50.</span><cite>Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging. Dodgshun AJ, Maixner WJ, Hansford JR, Sullivan MJ. J Neurosurg Pediatr. 2016;17:569–572. doi: 10.3171/2015.9.PEDS15449.</cite> [<a href="https://doi.org/10.3171/2015.9.PEDS15449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26722760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurosurg%20Pediatr&amp;title=Low%20rates%20of%20recurrence%20and%20slow%20progression%20of%20pediatric%20pilocytic%20astrocytoma%20after%20gross-total%20resection:%20justification%20for%20reducing%20surveillance%20imaging&amp;volume=17&amp;publication_year=2016&amp;pages=569-572&amp;pmid=26722760&amp;doi=10.3171/2015.9.PEDS15449&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF51">
<span class="label">51.</span><cite>A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702) Stokland T, Liu JF, Ironside JW, et al.  Neuro Oncol. 2010;12:1257–1268. doi: 10.1093/neuonc/noq092.</cite> [<a href="https://doi.org/10.1093/neuonc/noq092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3018938/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20861086/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=A%20multivariate%20analysis%20of%20factors%20determining%20tumor%20progression%20in%20childhood%20low-grade%20glioma:%20a%20population-based%20cohort%20study%20(CCLG%20CNS9702)&amp;volume=12&amp;publication_year=2010&amp;pages=1257-1268&amp;pmid=20861086&amp;doi=10.1093/neuonc/noq092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF52">
<span class="label">52.</span><cite>Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Bandopadhayay P, Bergthold G, London WB, et al.  Pediatr Blood Cancer. 2014;61:1173–1179. doi: 10.1002/pbc.24958.</cite> [<a href="https://doi.org/10.1002/pbc.24958" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4657506/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24482038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr%20Blood%20Cancer&amp;title=Long-term%20outcome%20of%204,040%20children%20diagnosed%20with%20pediatric%20low-grade%20gliomas:%20an%20analysis%20of%20the%20Surveillance%20Epidemiology%20and%20End%20Results%20(SEER)%20database&amp;volume=61&amp;publication_year=2014&amp;pages=1173-1179&amp;pmid=24482038&amp;doi=10.1002/pbc.24958&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF53">
<span class="label">53.</span><cite>Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: a report from the Children's Oncology Group. Ater JL, Xia C, Mazewski CM, et al.  Cancer. 2016;122:1928–1936. doi: 10.1002/cncr.29987.</cite> [<a href="https://doi.org/10.1002/cncr.29987" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4892942/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27061921/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Nonrandomized%20comparison%20of%20neurofibromatosis%20type%201%20and%20non-neurofibromatosis%20type%201%20children%20who%20received%20carboplatin%20and%20vincristine%20for%20progressive%20low-grade%20glioma:%20a%20report%20from%20the%20Children's%20Oncology%20Group&amp;volume=122&amp;publication_year=2016&amp;pages=1928-1936&amp;pmid=27061921&amp;doi=10.1002/cncr.29987&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF54">
<span class="label">54.</span><cite>Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study. Aquino VM, Fort DW, Kamen BA. J Neurooncol. 1999;41:255–259. doi: 10.1023/a:1006149809479.</cite> [<a href="https://doi.org/10.1023/a:1006149809479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10359145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurooncol&amp;title=Carboplatin%20for%20the%20treatment%20of%20children%20with%20newly%20diagnosed%20optic%20chiasm%20gliomas:%20a%20phase%20II%20study&amp;volume=41&amp;publication_year=1999&amp;pages=255-259&amp;pmid=10359145&amp;doi=10.1023/a:1006149809479&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF55">
<span class="label">55.</span><cite>Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy. Dodgshun AJ, Maixner WJ, Heath JA, Sullivan MJ, Hansford JR. Int J Cancer. 2016;138:481–488. doi: 10.1002/ijc.29711.</cite> [<a href="https://doi.org/10.1002/ijc.29711" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26235348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&amp;title=Single%20agent%20carboplatin%20for%20pediatric%20low-grade%20glioma:%20A%20retrospective%20analysis%20shows%20equivalent%20efficacy%20to%20multiagent%20chemotherapy&amp;volume=138&amp;publication_year=2016&amp;pages=481-488&amp;pmid=26235348&amp;doi=10.1002/ijc.29711&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF56">
<span class="label">56.</span><cite>Phase II weekly vinblastine for chemotherapy-naïve children with progressive low-grade glioma: a Canadian pediatric brain tumor consortium study. Lassaletta A, Scheinemann K, Zelcer SM, et al.  J Clin Oncol. 2016;34:3537–3543. doi: 10.1200/JCO.2016.68.1585.</cite> [<a href="https://doi.org/10.1200/JCO.2016.68.1585" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27573663/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Phase%20II%20weekly%20vinblastine%20for%20chemotherapy-na%C3%AFve%20children%20with%20progressive%20low-grade%20glioma:%20a%20Canadian%20pediatric%20brain%20tumor%20consortium%20study&amp;volume=34&amp;publication_year=2016&amp;pages=3537-3543&amp;pmid=27573663&amp;doi=10.1200/JCO.2016.68.1585&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF57">
<span class="label">57.</span><cite>Phase II trial of conformal radiation therapy for pediatric low-grade glioma. Merchant TE, Kun LE, Wu S, Xiong X, Sanford RA, Boop FA. J Clin Oncol. 2009;27:3598–3604. doi: 10.1200/JCO.2008.20.9494.</cite> [<a href="https://doi.org/10.1200/JCO.2008.20.9494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3525947/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19581536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Phase%20II%20trial%20of%20conformal%20radiation%20therapy%20for%20pediatric%20low-grade%20glioma&amp;volume=27&amp;publication_year=2009&amp;pages=3598-3604&amp;pmid=19581536&amp;doi=10.1200/JCO.2008.20.9494&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF58">
<span class="label">58.</span><cite>Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. Packer RJ, Lange B, Ater J, et al.  J Clin Oncol. 1993;11:850–856. doi: 10.1200/JCO.1993.11.5.850.</cite> [<a href="https://doi.org/10.1200/JCO.1993.11.5.850" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8487049/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Carboplatin%20and%20vincristine%20for%20recurrent%20and%20newly%20diagnosed%20low-grade%20gliomas%20of%20childhood&amp;volume=11&amp;publication_year=1993&amp;pages=850-856&amp;pmid=8487049&amp;doi=10.1200/JCO.1993.11.5.850&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF59">
<span class="label">59.</span><cite>Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood. Saran FH, Baumert BG, Khoo VS, Adams EJ, Garré ML, Warrington AP, Brada M. Int J Radiat Oncol Biol Phys. 2002;53:43–51. doi: 10.1016/s0360-3016(02)02734-7.</cite> [<a href="https://doi.org/10.1016/s0360-3016(02)02734-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12007940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;title=Stereotactically%20guided%20conformal%20radiotherapy%20for%20progressive%20low-grade%20gliomas%20of%20childhood&amp;volume=53&amp;publication_year=2002&amp;pages=43-51&amp;pmid=12007940&amp;doi=10.1016/s0360-3016(02)02734-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF60">
<span class="label">60.</span><cite>Outcomes following proton therapy for pediatric low-grade glioma. Indelicato DJ, Rotondo RL, Uezono H, et al.  Int J Radiat Oncol Biol Phys. 2019;104:149–156. doi: 10.1016/j.ijrobp.2019.01.078.</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2019.01.078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30684665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;title=Outcomes%20following%20proton%20therapy%20for%20pediatric%20low-grade%20glioma&amp;volume=104&amp;publication_year=2019&amp;pages=149-156&amp;pmid=30684665&amp;doi=10.1016/j.ijrobp.2019.01.078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF61">
<span class="label">61.</span><cite>Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. Merchant TE, Conklin HM, Wu S, Lustig RH, Xiong X. J Clin Oncol. 2009;27:3691–3697. doi: 10.1200/JCO.2008.21.2738.</cite> [<a href="https://doi.org/10.1200/JCO.2008.21.2738" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2799064/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19581535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Late%20effects%20of%20conformal%20radiation%20therapy%20for%20pediatric%20patients%20with%20low-grade%20glioma:%20prospective%20evaluation%20of%20cognitive,%20endocrine,%20and%20hearing%20deficits&amp;volume=27&amp;publication_year=2009&amp;pages=3691-3697&amp;pmid=19581535&amp;doi=10.1200/JCO.2008.21.2738&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF62">
<span class="label">62.</span><cite>Radiation therapy of optico-hypothalamic gliomas (OHG)-radiographic response, vision and late toxicity. Grabenbauer GG, Schuchardt U, Buchfelder M, et al.  Radiother Oncol. 2000;54:239–245. doi: 10.1016/s0167-8140(00)00149-3.</cite> [<a href="https://doi.org/10.1016/s0167-8140(00)00149-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10738082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiother%20Oncol&amp;title=Radiation%20therapy%20of%20optico-hypothalamic%20gliomas%20(OHG)-radiographic%20response,%20vision%20and%20late%20toxicity&amp;volume=54&amp;publication_year=2000&amp;pages=239-245&amp;pmid=10738082&amp;doi=10.1016/s0167-8140(00)00149-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF63">
<span class="label">63.</span><cite>Management of optic pathway and chiasmatic-hypothalamic gliomas in children with radiation therapy. Erkal HŞ, Serin M, Çakmak A. Radiother Oncol. 1997;45:11–15. doi: 10.1016/s0167-8140(97)00102-3.</cite> [<a href="https://doi.org/10.1016/s0167-8140(97)00102-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9364626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiother%20Oncol&amp;title=Management%20of%20optic%20pathway%20and%20chiasmatic-hypothalamic%20gliomas%20in%20children%20with%20radiation%20therapy&amp;volume=45&amp;publication_year=1997&amp;pages=11-15&amp;pmid=9364626&amp;doi=10.1016/s0167-8140(97)00102-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF64">
<span class="label">64.</span><cite>Advances in the management of low-grade gliomas. Nageswara Rao AA, Packer RJ. Curr Oncol Rep. 2014;16:398. doi: 10.1007/s11912-014-0398-9.</cite> [<a href="https://doi.org/10.1007/s11912-014-0398-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24925153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Oncol%20Rep&amp;title=Advances%20in%20the%20management%20of%20low-grade%20gliomas&amp;volume=16&amp;publication_year=2014&amp;pages=398&amp;pmid=24925153&amp;doi=10.1007/s11912-014-0398-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF65">
<span class="label">65.</span><cite>A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. Banerjee A, Jakacki RI, Onar-Thomas A, et al.  Neuro Oncol. 2017;19:1135–1144. doi: 10.1093/neuonc/now282.</cite> [<a href="https://doi.org/10.1093/neuonc/now282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5570236/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28339824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=A%20phase%20I%20trial%20of%20the%20MEK%20inhibitor%20selumetinib%20(AZD6244)%20in%20pediatric%20patients%20with%20recurrent%20or%20refractory%20low-grade%20glioma:%20a%20Pediatric%20Brain%20Tumor%20Consortium%20(PBTC)%20study&amp;volume=19&amp;publication_year=2017&amp;pages=1135-1144&amp;pmid=28339824&amp;doi=10.1093/neuonc/now282&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF66">
<span class="label">66.</span><cite>A phase II re-treatment study of selumetinib for recurrent or progressive pediatric low-grade glioma (PLGG): a pediatric brain tumor Consortium (PBTC) study. Fangusaro J, Onar-Thomas A, Wu S, et al.  Neuro Oncol. 2020;22:0. doi: 10.1093/neuonc/noac029.</cite> [<a href="https://doi.org/10.1093/neuonc/noac029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9340620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35307742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%20Oncol&amp;title=A%20phase%20II%20re-treatment%20study%20of%20selumetinib%20for%20recurrent%20or%20progressive%20pediatric%20low-grade%20glioma%20(PLGG):%20a%20pediatric%20brain%20tumor%20Consortium%20(PBTC)%20study&amp;volume=22&amp;publication_year=2020&amp;pages=0&amp;pmid=35307742&amp;doi=10.1093/neuonc/noac029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF67">
<span class="label">67.</span><cite>Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy. Cipri S, Del Baldo G, Fabozzi F, Boccuto L, Carai A, Mastronuzzi A. Front Oncol. 2023;13:1204829. doi: 10.3389/fonc.2023.1204829.</cite> [<a href="https://doi.org/10.3389/fonc.2023.1204829" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10311254/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37397394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Unlocking%20the%20power%20of%20precision%20medicine%20for%20pediatric%20low-grade%20gliomas:%20molecular%20characterization%20for%20targeted%20therapies%20with%20enhanced%20safety%20and%20efficacy&amp;volume=13&amp;publication_year=2023&amp;pages=1204829&amp;pmid=37397394&amp;doi=10.3389/fonc.2023.1204829&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF68">
<span class="label">68.</span><cite>Clinical characteristics and detection of MYB-QKI fusions in patients with angiocentric glioma. Li T, Aihemaitiniyazi A, Zhang H, et al.  Neurol Sci. 2025;46:427–436. doi: 10.1007/s10072-024-07721-3.</cite> [<a href="https://doi.org/10.1007/s10072-024-07721-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11698799/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39098857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurol%20Sci&amp;title=Clinical%20characteristics%20and%20detection%20of%20MYB-QKI%20fusions%20in%20patients%20with%20angiocentric%20glioma&amp;volume=46&amp;publication_year=2025&amp;pages=427-436&amp;pmid=39098857&amp;doi=10.1007/s10072-024-07721-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF69">
<span class="label">69.</span><cite>Angiocentric glioma with MYB-QKI fusion located in the brainstem, rather than cerebral cortex. Chan E, Bollen AW, Sirohi D, et al.  Acta Neuropathol. 2017;134:671–673. doi: 10.1007/s00401-017-1759-x.</cite> [<a href="https://doi.org/10.1007/s00401-017-1759-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5693679/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28776091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol&amp;title=Angiocentric%20glioma%20with%20MYB-QKI%20fusion%20located%20in%20the%20brainstem,%20rather%20than%20cerebral%20cortex&amp;volume=134&amp;publication_year=2017&amp;pages=671-673&amp;pmid=28776091&amp;doi=10.1007/s00401-017-1759-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF70">
<span class="label">70.</span><cite>MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Bandopadhayay P, Ramkissoon LA, Jain P, et al.  Nat Genet. 2016;48:273–282. doi: 10.1038/ng.3500.</cite> [<a href="https://doi.org/10.1038/ng.3500" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4767685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26829751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=MYB-QKI%20rearrangements%20in%20angiocentric%20glioma%20drive%20tumorigenicity%20through%20a%20tripartite%20mechanism&amp;volume=48&amp;publication_year=2016&amp;pages=273-282&amp;pmid=26829751&amp;doi=10.1038/ng.3500&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF71">
<span class="label">71.</span><cite>P118: Two cases of angiocentric glioma with MYB:: QKI fusion in a single institution. Kumar D, Kiran F, Gener M, Kats A, Zhang L. Genetics in Medicine Open. 2024;2</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Genetics%20in%20Medicine%20Open&amp;title=P118:%20Two%20cases%20of%20angiocentric%20glioma%20with%20MYB::%20QKI%20fusion%20in%20a%20single%20institution&amp;volume=2&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF72">
<span class="label">72.</span><cite>Phase I study of vemurafenib in children with recurrent or progressive BRAF(V600E) mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002) Nicolaides T, Nazemi KJ, Crawford J, et al.  Oncotarget. 2020;11:1942–1952. doi: 10.18632/oncotarget.27600.</cite> [<a href="https://doi.org/10.18632/oncotarget.27600" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7260122/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32523649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Phase%20I%20study%20of%20vemurafenib%20in%20children%20with%20recurrent%20or%20progressive%20BRAF(V600E)%20mutant%20brain%20tumors:%20Pacific%20Pediatric%20Neuro-Oncology%20Consortium%20study%20(PNOC-002)&amp;volume=11&amp;publication_year=2020&amp;pages=1942-1952&amp;pmid=32523649&amp;doi=10.18632/oncotarget.27600&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF73">
<span class="label">73.</span><cite>Pediatric low-grade glioma in the era of molecular diagnostics. Ryall S, Tabori U, Hawkins C. Acta Neuropathol Commun. 2020;8:30. doi: 10.1186/s40478-020-00902-z.</cite> [<a href="https://doi.org/10.1186/s40478-020-00902-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7066826/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32164789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathol%20Commun&amp;title=Pediatric%20low-grade%20glioma%20in%20the%20era%20of%20molecular%20diagnostics&amp;volume=8&amp;publication_year=2020&amp;pages=30&amp;pmid=32164789&amp;doi=10.1186/s40478-020-00902-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF74">
<span class="label">74.</span><cite>Fibroblast growth factor receptors (FGFRs): structures and small molecule inhibitors
. Dai S, Zhou Z, Chen Z, Xu G, Chen Y. Cells. 2019;8:614. doi: 10.3390/cells8060614.</cite> [<a href="https://doi.org/10.3390/cells8060614" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6627960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31216761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Fibroblast%20growth%20factor%20receptors%20(FGFRs):%20structures%20and%20small%20molecule%20inhibitors&amp;volume=8&amp;publication_year=2019&amp;pages=614&amp;pmid=31216761&amp;doi=10.3390/cells8060614&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cureus are provided here courtesy of <strong>Cureus Inc.</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.7759/cureus.88575"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/cureus-0017-00000088575.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (7.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372413/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372413/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372413%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372413/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372413/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372413/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372413/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372413/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372413/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="CSchbAUQ929elD8mZ1AmfLkENq6k5zTXwEzP45ZworNHNALWp7Z7wK4GjshXagRZ">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
